Afam Capital Decreased Its American Eagle Outfitters (AEO) Stake; Merrimack Pharmaceuticals, Inc. (MACK) Had 2 Bulls

February 19, 2018 - By Linda Rogers

Among 5 analysts covering Merrimack Pharmaceuticals (NASDAQ:MACK), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Merrimack Pharmaceuticals had 10 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) earned “Neutral” rating by Robert W. Baird on Friday, May 27. JP Morgan downgraded the shares of MACK in report on Friday, October 7 to “Neutral” rating. The firm has “Hold” rating given on Friday, October 13 by Robert W. Baird. The rating was maintained by Mizuho with “Buy” on Wednesday, December 23. The stock has “Buy” rating by Brean Capital on Tuesday, August 11. Mizuho maintained Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) rating on Wednesday, August 12. Mizuho has “Outperform” rating and $16 target. The firm earned “Neutral” rating on Friday, August 19 by BTIG Research. Oppenheimer reinitiated the shares of MACK in report on Wednesday, August 12 with “Outperform” rating. Oppenheimer maintained Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) rating on Tuesday, October 27. Oppenheimer has “Outperform” rating and $15 target. The firm has “Hold” rating given on Monday, September 11 by Robert W. Baird. See Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) latest ratings:

13/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $15.0 Maintain
11/09/2017 Broker: Robert W. Baird Rating: Hold New Target: $15.0 Maintain

Afam Capital Inc decreased American Eagle Outfitters (AEO) stake by 6.37% reported in 2017Q3 SEC filing. Afam Capital Inc sold 25,478 shares as American Eagle Outfitters (AEO)’s stock declined 29.04%. The Afam Capital Inc holds 374,326 shares with $5.35M value, down from 399,804 last quarter. American Eagle Outfitters now has $3.27 billion valuation. The stock increased 1.43% or $0.26 during the last trading session, reaching $18.44. About 3.14M shares traded. American Eagle Outfitters, Inc. (NYSE:AEO) has declined 31.50% since February 19, 2017 and is downtrending. It has underperformed by 48.20% the S&P500.

Afam Capital Inc increased Ishares Msci South Africa Index (EZA) stake by 26,575 shares to 131,443 valued at $7.72M in 2017Q3. It also upped Netapp Inc (NASDAQ:NTAP) stake by 11,063 shares and now owns 19,009 shares. Vanguard Short (BSV) was raised too.

Analysts await American Eagle Outfitters, Inc. (NYSE:AEO) to report earnings on March, 7. They expect $0.44 earnings per share, up 12.82% or $0.05 from last year’s $0.39 per share. AEO’s profit will be $78.03 million for 10.48 P/E if the $0.44 EPS becomes a reality. After $0.37 actual earnings per share reported by American Eagle Outfitters, Inc. for the previous quarter, Wall Street now forecasts 18.92% EPS growth.

Among 27 analysts covering American Eagle Outfitters (NYSE:AEO), 14 have Buy rating, 1 Sell and 12 Hold. Therefore 52% are positive. American Eagle Outfitters had 89 analyst reports since August 4, 2015 according to SRatingsIntel. The stock has “Mkt Perform” rating by FBR Capital on Thursday, March 2. The rating was upgraded by Bank of America on Tuesday, August 2 to “Buy”. As per Monday, January 11, the company rating was downgraded by Telsey Advisory Group. The firm earned “Sell” rating on Thursday, August 18 by Goldman Sachs. The stock of American Eagle Outfitters, Inc. (NYSE:AEO) earned “Buy” rating by Jefferies on Friday, September 8. The firm has “Buy” rating given on Friday, November 10 by SunTrust. Mizuho maintained American Eagle Outfitters, Inc. (NYSE:AEO) rating on Friday, January 8. Mizuho has “Neutral” rating and $16.0 target. B. Riley & Co upgraded the shares of AEO in report on Wednesday, November 4 to “Buy” rating. The company was maintained on Friday, February 2 by SunTrust. The stock has “Buy” rating by SunTrust on Thursday, August 24.

The stock increased 0.74% or $0.08 during the last trading session, reaching $10.82. About 93,792 shares traded. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) has declined 44.78% since February 19, 2017 and is downtrending. It has underperformed by 61.48% the S&P500.

Since September 11, 2017, it had 0 insider purchases, and 2 selling transactions for $422,765 activity. $112,357 worth of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) shares were sold by Nielsen Ulrik B..

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>